Report: Screening programs in Italy (Italy): Difference between revisions
No edit summary |
No edit summary |
||
| Line 9: | Line 9: | ||
'''Data level:''' National and regional level. | '''Data level:''' National and regional level. | ||
'''Cancer areas of interest:''' [[hasCancerType::C00-D48: All neoplasms]]. [https://www.salute.gov.it/portale/documentazione/p6_2_2_1.jsp?lingua=italiano&id=2305 Click here to learn more]. | |||
'''Access to information:''' [https://www.salute.gov.it/portale/documentazione/p6_2_2_1.jsp?lingua=italiano&id=2305 Click here to access]. | '''Access to information:''' [https://www.salute.gov.it/portale/documentazione/p6_2_2_1.jsp?lingua=italiano&id=2305 Click here to access]. | ||
Revision as of 21:23, 22 May 2024
Go back to Italy page
Sponsor, manager or home institution: Osservatorio Nazionale Screening; Ministero della Salute.
Primary purpose: Assesses annual cancer screening programs in Italy, indicating substantial participation in mammography and cervical screenings, significant progress in colorectal screening, and disparities in coverage between regions.
Type of information: Effective extent of mammography, cervical and colorectal screening; Participation (%) in screenings according to the country of origin; Waiting times; Invitations; Availability of pre-operative diagnosis; Conservative surgery; Total number of persons invited Number of persons participating in the invitation; Acceptance of the invitation; Number of persons examined in the period; Proportion of persons recalled for further investigation; Benign biopsies; Cancer identification rate; Invasive cancer identification rate; Percentage of conservative surgical treatment in invasive tumors; Mammography performed within the last 2 years; Fecal occult blood test programs - Main results in the two-year period; Programs with Rectosigmoidoscopy; Examination for the prevention of colorectal cancer in the recommended times (%) persons; Lesions with CIN2+ histology identified; Introduction of the human papilloma virus (Hpv) test as a screening test; Preventive test coverage in the last 3 years.
Data level: National and regional level.
Cancer areas of interest: C00-D48: All neoplasms. Click here to learn more.
Access to information: Click here to access.